Comments to prediction of advanced fibrosis in nonalcoholic fatty liver disease: an enhanced model of BARD score.
作者信息
Guan Yong-Song
机构信息
Department of Oncology, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China.
出版信息
Gut Liver. 2014 Mar;8(2):228. doi: 10.5009/gnl.2014.8.2.228. Epub 2014 Mar 11.
Abstract
摘要
相似文献
1
Comments to prediction of advanced fibrosis in nonalcoholic fatty liver disease: an enhanced model of BARD score.非酒精性脂肪性肝病中晚期纤维化预测的评论：BARD评分的增强模型
Gut Liver. 2014 Mar;8(2):228. doi: 10.5009/gnl.2014.8.2.228. Epub 2014 Mar 11.
2
Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score.非酒精性脂肪性肝病中晚期纤维化的预测：BARD 评分增强模型。
Gut Liver. 2013 May;7(3):323-8. doi: 10.5009/gnl.2013.7.3.323. Epub 2013 Apr 25.
3
Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).验证 BARD 评分系统在波兰非酒精性脂肪性肝病（NAFLD）患者中的应用。
BMC Gastroenterol. 2010 Jun 28;10:67. doi: 10.1186/1471-230X-10-67.
4
The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease.BARD 评分和 NAFLD 纤维化评分在非酒精性脂肪性肝病中评估进展性肝纤维化的价值。
Med Sci Monit. 2012 Dec;18(12):CR735-40. doi: 10.12659/msm.883601.
5
Elevated red cell distribution width is associated with advanced fibrosis in NAFLD.红细胞分布宽度升高与非酒精性脂肪性肝病的肝纤维化程度相关。
Clin Mol Hepatol. 2013 Sep;19(3):258-65. doi: 10.3350/cmh.2013.19.3.258. Epub 2013 Sep 30.
6
Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease.代谢相关脂肪性肝病患者中传统非侵入性纤维化评分系统的验证。
World J Gastroenterol. 2021 Sep 14;27(34):5753-5763. doi: 10.3748/wjg.v27.i34.5753.
7
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.非酒精性脂肪性肝病患者中丙氨酸氨基转移酶正常的无创性评分系统。
J Gastroenterol. 2013 Sep;48(9):1051-60. doi: 10.1007/s00535-012-0704-y. Epub 2012 Nov 27.
8
Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease.逐步组合简单的非侵入性纤维化评分系统可提高非酒精性脂肪性肝病的诊断准确性。
J Clin Gastroenterol. 2013 Sep;47(8):719-26. doi: 10.1097/MCG.0b013e3182819a89.
9
Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study.FIB-4指数、非酒精性脂肪性肝病纤维化评分和BARD评分预测成年非酒精性脂肪性肝病患者严重纤维化的比较：一项荟萃分析研究。
Hepatol Res. 2016 Aug;46(9):862-70. doi: 10.1111/hepr.12647. Epub 2016 Feb 16.
10
Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease.巴德评分系统在非酒精性脂肪性肝病肥胖症手术患者中的表现。
Obes Surg. 2017 Feb;27(2):394-398. doi: 10.1007/s11695-016-2284-z.
本文引用的文献
1
Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin.因华法林治疗患者持续呕吐导致维生素 K 摄入减少而引起的治疗窗上移国际标准化比值。
Ann Pharmacother. 2013 Jun;47(6):e28. doi: 10.1345/aph.1R688.
2
Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score.非酒精性脂肪性肝病中晚期纤维化的预测：BARD 评分增强模型。
Gut Liver. 2013 May;7(3):323-8. doi: 10.5009/gnl.2013.7.3.323. Epub 2013 Apr 25.
3
Possible warfarin resistance due to interaction with ascorbic acid: case report and literature review.可能由于与抗坏血酸相互作用导致华法林抵抗：病例报告及文献复习。
Am J Health Syst Pharm. 2013 May 1;70(9):782-6. doi: 10.2146/ajhp110704.
4
Long-term stability of frozen pooled plasmas stored at -70°C, -40°C, and -20°C for prothrombin time and International Normalized Ratio (INR) assessment.冷冻混合血浆在-70°C、-40°C 和-20°C 下储存的凝血酶原时间和国际标准化比值（INR）评估的长期稳定性。
Thromb Res. 2013 Apr;131(4):349-51. doi: 10.1016/j.thromres.2013.01.020. Epub 2013 Feb 12.
5
The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation.对华法林与蔓越莓汁相互作用的再探讨：一项系统的体外-体内评估。
J Exp Pharmacol. 2010 Jul;2010(2):83-91. doi: 10.2147/JEP.S11719.
6
Effect of tobacco on INR.烟草对国际标准化比值（INR）的影响。
Am J Health Syst Pharm. 2007 Apr 15;64(8):804; author reply 805. doi: 10.2146/ajhp060666.
7
Effects of prednisone on the International Normalized Ratio.泼尼松对国际标准化比值的影响。
Am J Health Syst Pharm. 2006 Dec 1;63(23):2354-6. doi: 10.2146/ajhp060105.
8
Leflunomide and warfarin interaction: case report and review of the literature.来氟米特与华法林的相互作用：病例报告及文献综述
Pharmacotherapy. 2006 Jun;26(6):868-71. doi: 10.1592/phco.26.6.868.
Zotero 插件